{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:08:49Z","timestamp":1764601729131,"version":"3.41.2"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2019-3182"],"award-info":[{"award-number":["2019-3182"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Transcriptional enhanced associate domain (TEAD) is a family of transcription factors that plays a significant role during embryonic developmental processes, and its dysregulation is responsible for tumour progression. TEAD is considered as druggable targets in various diseases, namely cancer, cardiovascular diseases and neurodegenerative disorders.<\/jats:p>\n               <jats:p>Previous structural studies revealed the importance of the central hydrophobic pocket of TEAD as a potential target for small-molecule inhibitors and demonstrated flufenamic acid (FLU) (a COX-2 enzyme inhibitor) to bind and inhibit TEAD2 functions. However, to date, no drug candidates that bind specifically to TEAD2 with high selectivity and efficacy have been developed or proposed.<\/jats:p>\n               <jats:p>Within this framework, we present here a case study where we have identified potential TEAD2 inhibitor candidates by integrating multiple computational approaches. Among the candidates, the top two ranked compounds ZINC95969481 (LG1) which is a fused pyrazole derivative and ZINC05203789 (LG2), a fluorene derivative resulted in much favourable binding energy scores than the reference ligand, FLU. The drug likeliness of the best compounds was also evaluated in silico to ensure the bioavailability of these compounds particularly LG1 as compared to FLU thus providing a strong rationale for their development as leads against TEAD. Molecular dynamics simulations results highlighted the role of key residues contributing to favourable interactions in TEAD2-LG1 complex with much favourable interaction and binding free energy values with respect to the reference compound. Altogether, this study provides a starting platform to be more exploited by future experimental research towards the development of inhibitors against TEAD, a persuasive strategy for therapeutic intervention in cancer treatment.<\/jats:p>","DOI":"10.1093\/bib\/bbab007","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T21:35:33Z","timestamp":1610055333000},"source":"Crossref","is-referenced-by-count":10,"title":["Exploring TEAD2 as a drug target for therapeutic intervention of cancer: A multi-computational case study"],"prefix":"10.1093","volume":"22","author":[{"given":"Rajesh","family":"Pal","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, University of Cagliari, Italy"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Electrical and Electronic Engineering, University of Cagliari, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0759-4174","authenticated-orcid":false,"given":"Gauri","family":"Misra","sequence":"additional","affiliation":[{"name":"Amity University, Sector-125, Noida, India"},{"name":"Present Address: National Institute of Biologicals, A-32, Institutional Area, Block-A, Industrial Area, Sector-62, Noida-201309, Uttar Pradesh, India"}]}],"member":"286","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"2021090813434598000_ref1","doi-asserted-by":"crossref","DOI":"10.1002\/j.1460-2075.1987.tb02606.x","article-title":"One cell-specific and three ubiquitous nuclear proteins bind in vitro to overlapping motifs in the domain B1 of the SV40 enhancer","author":"Xiao","year":"1987","journal-title":"EMBO J"},{"key":"2021090813434598000_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(88)90108-0","article-title":"The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence","author":"Davidson","year":"1988","journal-title":"Cell"},{"key":"2021090813434598000_ref3","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/j.1460-2075.1992.tb05286.x","article-title":"Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells","volume":"11","author":"Ishiji","year":"1992","journal-title":"EMBO J"},{"issue":"24","key":"2021090813434598000_ref4","doi-asserted-by":"crossref","first-page":"17234","DOI":"10.1016\/S0021-9258(18)41917-5","article-title":"M-CAT binding factor is related to the SV40 enhancer binding factor, TEF-1","volume":"267","author":"Farrance","year":"1992","journal-title":"J Biol Chem"},{"key":"2021090813434598000_ref5","doi-asserted-by":"publisher","DOI":"10.1101\/gad.8.19.2293","article-title":"Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice","author":"Chen","year":"1994","journal-title":"Genes Dev"},{"key":"2021090813434598000_ref6","doi-asserted-by":"publisher","DOI":"10.1002\/dvg.20330","article-title":"Transcription factor TEAD2 is involved in neural tube closure","author":"Kaneko","year":"2007","journal-title":"Genesis"},{"key":"2021090813434598000_ref7","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01759-07","article-title":"Redundant roles of Tead1 and Tead2 in notochord development and the regulation of cell proliferation and survival","author":"Sawada","year":"2008","journal-title":"Mol Cell Biol"},{"key":"2021090813434598000_ref8","doi-asserted-by":"publisher","DOI":"10.1242\/dev.010223","article-title":"Transcription factor TEAD4 specifies the trophectoderm lineage at the beginning of mammalian development","author":"Yagi","year":"2007","journal-title":"Development"},{"key":"2021090813434598000_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90088-G","article-title":"Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1","author":"Xiao","year":"1991","journal-title":"Cell"},{"key":"2021090813434598000_ref10","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1664408","article-title":"TEAD mediates YAP-dependent gene induction and growth control","author":"Zhao","year":"2008","journal-title":"Genes Dev"},{"key":"2021090813434598000_ref11","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2711","article-title":"Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF","author":"Lai","year":"2011","journal-title":"Cancer Res"},{"key":"2021090813434598000_ref12","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01874-07","article-title":"TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway","author":"Lei","year":"2008","journal-title":"Mol Cell Biol"},{"key":"2021090813434598000_ref13","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1865310","article-title":"Structural basis of YAP recognition by TEAD4 in the hippo pathway","author":"Chen","year":"2010","journal-title":"Genes Dev"},{"key":"2021090813434598000_ref14","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1865810","article-title":"Structural insights into the YAP and TEAD complex","author":"Li","year":"2010","journal-title":"Genes Dev"},{"key":"2021090813434598000_ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02219-9","article-title":"Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex","author":"Kaan","year":"2017","journal-title":"Sci Rep"},{"key":"2021090813434598000_ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nature22366","article-title":"Architecture of the human interactome defines protein communities and disease networks","author":"Huttlin","year":"2017","journal-title":"Nature"},{"key":"2021090813434598000_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.06.043","article-title":"The BioPlex network: a systematic exploration of the human Interactome","author":"Huttlin","year":"2015","journal-title":"Cell"},{"key":"2021090813434598000_ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3876","article-title":"The emerging roles of YAP and TAZ in cancer","author":"Moroishi","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"2021090813434598000_ref19","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.23788","article-title":"Emerging roles of TEAD transcription factors and its coactivators in cancers","author":"Pobbati","year":"2013","journal-title":"Cancer Biology and Therapy"},{"key":"2021090813434598000_ref20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604774","article-title":"TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer","author":"Knight","year":"2008","journal-title":"Br J Cancer"},{"key":"2021090813434598000_ref21","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.342","article-title":"Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner","author":"Liu","year":"2016","journal-title":"Oncogene"},{"key":"2021090813434598000_ref22","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20550","article-title":"DNA copy number alterations and expression of relevant genes in triple-negative breast cancer","author":"Han","year":"2008","journal-title":"Genes Chromosom"},{"key":"2021090813434598000_ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045498","article-title":"Alteration of TEAD1 expression levels confers apoptotic resistance through the transcriptional up-regulation of Livin","author":"Landin Malt","year":"2012","journal-title":"PLoS One"},{"key":"2021090813434598000_ref24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0474","article-title":"High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor-dependent MCAT motif","author":"Hucl","year":"2007","journal-title":"Cancer Res"},{"key":"2021090813434598000_ref25","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3216","article-title":"Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth","author":"Zanconato","year":"2015","journal-title":"Nat Cell Biol"},{"key":"2021090813434598000_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.12.104","article-title":"Tead and AP1 coordinate transcription and motility","author":"Liu","year":"2016","journal-title":"Cell Rep"},{"key":"2021090813434598000_ref27","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7683","article-title":"Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state","author":"Verfaillie","year":"2015","journal-title":"Nat Commun"},{"key":"2021090813434598000_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2015.09.009","article-title":"Targeting the central pocket in human transcription factor TEAD as a potential cancer therapeutic strategy","author":"Pobbati","year":"2015","journal-title":"Structure"},{"key":"2021090813434598000_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2015.11.005","article-title":"Palmitoylation of TEAD transcription factors is required for their stability and function in hippo pathway signaling","author":"Noland","year":"2016","journal-title":"Structure"},{"key":"2021090813434598000_ref30","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2036","article-title":"Autopalmitoylation of TEAD proteins regulates transcriptional output of the hippo pathway","author":"Chan","year":"2016","journal-title":"Nat Chem Biol"},{"key":"2021090813434598000_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.01.010","article-title":"A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer","author":"Jiao","year":"2014","journal-title":"Cancer Cell"},{"key":"2021090813434598000_ref32","doi-asserted-by":"publisher","DOI":"10.1101\/gad.192856.112","article-title":"Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP","author":"Liu-Chittenden","year":"2012","journal-title":"Genes Dev"},{"issue":"3","key":"2021090813434598000_ref33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J Comput Aided Mol Des"},{"issue":"21","key":"2021090813434598000_ref34","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212 ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J Med Chem"},{"issue":"7","key":"2021090813434598000_ref35","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J Med Chem"},{"issue":"12","key":"2021090813434598000_ref36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK a prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J Comput Aided Mol Des"},{"issue":"1","key":"2021090813434598000_ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-23246-0","article-title":"Identification of new inhibitors against human great wall kinase using in silico approaches","volume":"8","author":"Ammarah","year":"2018","journal-title":"Sci Rep"},{"issue":"9","key":"2021090813434598000_ref38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2174\/092986612802084456","article-title":"Targeting the epidermal growth factor receptor: exploring the potential of novel inhibitor N-(3-ethynylphenyl)-6, 7-bis (2-methoxyethoxy) quinolin-4-amine using docking and molecular dynamics simulation","volume":"19","author":"Gupta","year":"2012","journal-title":"Protein Pept Lett"},{"issue":"3","key":"2021090813434598000_ref39","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12539-016-0204-5","article-title":"Understanding the interactions of high-mobility group of protein domain B1 with DNA adducts generated by platinum anticancer molecules using in silico approaches","volume":"10","author":"Misra","year":"2018","journal-title":"Interdiscip Sci Computational Life Sci"},{"volume-title":"QikProp, version 3.5","year":"2012","key":"2021090813434598000_ref40"},{"key":"2021090813434598000_ref41","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with namd","volume":"26","author":"Phillips","year":"2005","journal-title":"J Comput Chem"},{"key":"2021090813434598000_ref42","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1039\/C4NJ01903B","article-title":"Dynamical insights into the differential characteristics of mycobacterium avium subsp. Paratuberculosis peptide binding to hla-drb1 proteins associated with multiple sclerosis","volume":"39","author":"Kumar","year":"2015","journal-title":"New J Chem"},{"key":"2021090813434598000_ref43","doi-asserted-by":"crossref","first-page":"42496","DOI":"10.1038\/srep42496","article-title":"Dynamical footprint of cross-reactivity in a human autoimmune t-cell receptor","volume":"7","author":"Kumar","year":"2017","journal-title":"Sci Rep"},{"key":"2021090813434598000_ref44","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J Chem Phys"},{"key":"2021090813434598000_ref45","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/jcc.23381","article-title":"Grcarma: a fully automated task-oriented interface for the analysis of molecular dynamics trajectories","volume":"34","author":"Koukos","year":"2013","journal-title":"J Comput Chem"},{"key":"2021090813434598000_ref46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/ci600406v","article-title":"Solvated interaction energy (sie) for scoring protein\u2212ligand binding affinities. 1. Exploring the parameter space","volume":"47","author":"Na\u00efm","year":"2007","journal-title":"J Chem Inf Model"},{"key":"2021090813434598000_ref47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"Vmd: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph"},{"issue":"7","key":"2021090813434598000_ref48","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1021\/jm049092j","article-title":"Virtual screening workflow development guided by the \u201creceiver operating characteristic\u201d curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4","volume":"48","author":"Triballeau","year":"2005","journal-title":"J Med Chem"},{"issue":"4","key":"2021090813434598000_ref49","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jmgm.2008.07.004","article-title":"Towards more accurate pharmacophore modeling: multicomplex-based comprehensive pharmacophore map and most-frequent-feature pharmacophore model of CDK2","volume":"27","author":"Zou","year":"2008","journal-title":"J Mol Graph Model"},{"key":"2021090813434598000_ref50","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1039\/C6NJ03181A","article-title":"Review: biologically active pyrazole derivatives","volume":"41","author":"Ansari","year":"2017","journal-title":"New J Chem"},{"key":"2021090813434598000_ref51","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3389\/fchem.2019.00917","article-title":"Novel anticancer fused Pyrazole derivatives as EGFR and VEGFR-2 dual TK inhibitors","volume":"7","author":"Saleh","year":"2020","journal-title":"Front Chem"},{"issue":"1","key":"2021090813434598000_ref52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/10426500902758410","article-title":"Synthesis and antitumor activity of some novel pyrazole and thienopyrimidine derivatives","volume":"185","author":"Aly","year":"2009","journal-title":"Phosphorus, Sulfur, and Silicon"},{"key":"2021090813434598000_ref53","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/jhet.3208","article-title":"Synthesis and anticancer activity of some new fused pyrazoles and their glycoside derivatives","volume":"55","author":"Nassar","year":"2018","journal-title":"J Heterocyclic Chem"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/5\/bbab007\/40328090\/bbab007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/5\/bbab007\/40328090\/bbab007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T14:54:37Z","timestamp":1631112877000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbab007\/6145134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbab007","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"type":"print","value":"1467-5463"},{"type":"electronic","value":"1477-4054"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,2,22]]},"article-number":"bbab007"}}